                Figure 4.  CD8+ T-cell responses (ELISpot IFNÎ³) to HIV peptides as a function of vaccination route, expressed as cumulative percentages.Panel A, all volunteers (N = 68), and Panel B, volunteers who received 3 injections (N = 44). The numbers of volunteers who had mounted responses to at least one HIV peptide at weeks 2, 6, 14, 24 are given above the columns: after intradermal (ID, crosshatched) or intramuscular (IM, empty) injections.

